Janssen Sustainability Profile
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is a leading player in the global pharmaceutical industry, headquartered in the United States. Founded in 1953, the company has made significant strides in various therapeutic areas, including oncology, immunology, neuroscience, and infectious diseases. With a commitment to innovation, Janssen is renowned for its core products, such as innovative treatments for cancer and autoimmune disorders, which are distinguished by their efficacy and safety profiles. The company has achieved notable milestones, including the development of groundbreaking therapies that have transformed patient care. Janssen's strong market position is underscored by its extensive research and development efforts, which continue to drive advancements in medicine, making it a trusted name in healthcare worldwide.
DitchCarbon Score
How does Janssen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Janssen's score of 100 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Janssen Pharmaceuticals, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Johnson & Johnson, any emissions data or climate commitments would be inherited from its parent company. Janssen is aligned with Johnson & Johnson's sustainability initiatives, which include various climate commitments and reduction targets. However, specific reduction targets or achievements for Janssen are not detailed in the available information. The company participates in several industry-standard initiatives, including the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from Johnson & Johnson. While no absolute emissions figures are provided, Janssen's commitment to sustainability reflects a broader industry trend towards reducing carbon footprints and enhancing climate resilience. The absence of specific data underscores the importance of ongoing efforts in tracking and reporting emissions as part of corporate responsibility in the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Janssen's Industry?
How Carbon Intensive is Janssen's Location?
Janssen's Scope 3 Categories Breakdown
Janssen's Scope 3 emissions, which decreased by 2% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Top Scope 3 Categories
Janssen's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Janssen has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
